Early research (Phase 1)Study completedNCT02101125What this trial is testingDrug Interaction Study With RosuvastatinWho this might be right forImmunosuppression For Disease Bristol-Myers Squibb 26
Not applicableUnknownNCT02826811What this trial is testingRole of Anti-BK Virus Neutralizing Antibodies (BKV) as a Prognostic Marker for the Development of Nephropathy BKWho this might be right forGraft Dysfunction University Hospital, Strasbourg, France 170
Testing effectiveness (Phase 2)Study completedNCT01036009What this trial is testingWithdrawal of Immunosuppression and Donor Lymphocyte Infusions Following Allogeneic Transplant for Pediatric Hematologic MalignanciesWho this might be right forAcute LeukemiaAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia+7 more University of California, San Francisco 43
Early research (Phase 1)Study completedNCT00001737What this trial is testingCyclosporin Implant to Treat UveitisWho this might be right forEye DiseaseInflammationUveitis National Eye Institute (NEI) 10
Post-approval studies (Phase 4)UnknownNCT01550445What this trial is testingSteroid Withdrawal Immunosuppression After Renal TransplantationWho this might be right forDisorder Related to Renal Transplantation Ajou University School of Medicine 30
Testing effectiveness (Phase 2)Study completedNCT00795886What this trial is testingRapamycin for Immunosuppression and B Cell Modulation Post Stem Cell Transplant for Acute Lymphoblastic Leukemia (ALL)Who this might be right forAcute Lymphoblastic Leukemia University of Utah 63
Not applicableStudy completedNCT00626808What this trial is testingA Post Marketing Evaluation of the Effectiveness of FluMist Risk Minimization Plan in ChildrenWho this might be right forAsthmaWheezingImmunosuppression MedImmune LLC 321,697
Early research (Phase 1)Ended earlyNCT00303134What this trial is testingIslet Cell Transplants for DiabetesWho this might be right forDiabetes Mellitus, Type 1 Weill Medical College of Cornell University 3
Testing effectiveness (Phase 2)Study completedNCT01012492What this trial is testingPilot of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor HCTWho this might be right forAMLALLUndifferentiated Leukemia+9 more Boston Children's Hospital 11
Early research (Phase 1)Active Not RecruitingNCT05823571What this trial is testingItacitinib With High-dose Posttransplantation Cyclophosphamide in Older PatientsWho this might be right forLeukemia, AcuteMyelodysplastic SyndromesMyelomonocytic Leukemia, Chronic+5 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 32
Testing effectiveness (Phase 2)Study completedNCT01251575What this trial is testingSirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell TransplantWho this might be right forAdult Acute Lymphoblastic LeukemiaAdult Acute Myeloid LeukemiaAdult Diffuse Large B-Cell Lymphoma+21 more Fred Hutchinson Cancer Center 77
Testing effectiveness (Phase 2)Study completedNCT00027820What this trial is testingTotal-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney CancerWho this might be right forAdult Acute Myeloid Leukemia in RemissionChildhood Acute Lymphoblastic Leukemia in RemissionChildhood Acute Myeloid Leukemia in Remission+27 more Fred Hutchinson Cancer Center 106
Testing effectiveness (Phase 2)Study completedNCT00040482What this trial is testingHigh Dose Chemo/Radiotherapy and Hematopoietic Stem Cell Transplant for Patients With Multiple SclerosisWho this might be right forMultiple Sclerosis Baylor College of Medicine 10
Large-scale testing (Phase 3)Looking for participantsNCT06059989What this trial is testingInDuctIon TREatment with SubCuTaneous Infliximab for Crohn's DiseaseWho this might be right forInflammatory DiseaseDisease CrohnBowel Disease Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 158
Early research (Phase 1)Ended earlyNCT00589316What this trial is testingIodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Donor Bone Marrow Transplant in Treating Patients With Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or High-Risk Myelodysplastic SyndromeWho this might be right forAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+7 more Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)Study completedNCT04870333What this trial is testingPROphylaxis for paTiEnts at Risk of COVID-19 infecTion -VWho this might be right forCovid19 Cambridge University Hospitals NHS Foundation Trust 2,240
Not applicableLooking for participantsNCT04622423What this trial is testingAdvanced Therapies for Liver MetastasesWho this might be right forPancreatic Ductal Adenocarcinoma (PDAC)Colorectal Cancer (CRC)Liver Metastasis+1 more IRCCS San Raffaele 625
Not applicableStudy completedNCT00116090What this trial is testingSystemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort StudyWho this might be right forUveitisCancerInfection+2 more National Eye Institute (NEI) 6,300
Not applicableUnknownNCT04657562What this trial is testingThe New LC-MS/MS Method for Determination of Unbound Tacrolimus in PlasmaWho this might be right forImmunosuppressionKidney Transplant RejectionKidney Transplant; Complications+4 more National Science Centre, Poland 380
Large-scale testing (Phase 3)Study completedNCT00328770What this trial is testingDe Novo Sirolimus-based Immunosuppression After Liver Transplantation for Hepatocellular CarcinomaWho this might be right forLiver Carcinoma University of Alberta 70